Deerfield Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$143M Buy
15,038,000
+697,000
+5% +$5.41M 1.69% 16
2025
Q4
$112M Buy
14,341,000
+2,172,000
+18% +$15.7M 1.43% 23
2025
Q3
$92.4M Buy
12,169,000
+7,477,000
+159% +$62.3M 1.42% 20
2025
Q2
$42M Sell
4,692,000
-497,665
-10% -$4.63M 0.76% 32
2025
Q1
$38.9M Sell
5,189,665
-2,954,777
-36% -$23.8M 0.77% 30
2024
Q4
$61.2M Buy
8,144,442
+8,638
+0.1% +$65.6K 1.17% 25
2024
Q3
$61.8M Hold
8,135,804
0.92% 24
2024
Q2
$50.3M Buy
8,135,804
+3,140,804
+63% +$17.3M 0.84% 30
2024
Q1
$25.4M Buy
4,995,000
+455,475
+10% +$2.56M 0.44% 43
2023
Q4
$27.2M Buy
4,539,525
+1,253,525
+38% +$7.26M 0.5% 38
2023
Q3
$23.3M Buy
3,286,000
+1,964,000
+149% +$14.1M 0.51% 40
2023
Q2
$9.31M Sell
1,322,000
-1,443,000
-52% -$11.6M 0.2% 73
2023
Q1
$23.1M Buy
+2,765,000
New +$26.6M 0.51% 50
2022
Q2
Sell
-1,012,000
Closed -$16.5M 127
2022
Q1
$16.5M Sell
1,012,000
-674,140
-40% -$10.8M 0.37% 56
2021
Q4
$23.4M Buy
1,686,140
+1,451,497
+619% +$19.2M 0.49% 48
2021
Q3
$3.37M Sell
234,643
-2,600,357
-92% -$41M 0.07% 115
2021
Q2
$44.8M Buy
2,835,000
+229,620
+9% +$3.12M 0.8% 41
2021
Q1
$26.5M Sell
2,605,380
-3,230,430
-55% -$33.3M 0.56% 61
2020
Q4
$43.5M Buy
5,835,810
+1,379,291
+31% +$7.11M 0.86% 35
2020
Q3
$15.3M Hold
4,456,519
0.37% 69
2020
Q2
$21.2M Sell
4,456,519
-196,407
-4% -$784K 0.62% 54
2020
Q1
$9.31M Sell
4,652,926
-1,722,217
-27% -$4.74M 0.3% 70
2019
Q4
$22M Buy
6,375,143
+3,600,500
+130% +$9.06M 0.7% 46
2019
Q3
$7.95M Sell
2,774,643
-3,518,337
-56% -$10.9M 0.32% 63
2019
Q2
$23.9M Sell
6,292,980
-244,586
-4% -$1.47M 0.86% 43
2019
Q1
$53.2M Sell
6,537,566
-373,223
-5% -$3.2M 2.04% 14
2018
Q4
$55.8M Hold
6,910,789
2.27% 11
2018
Q3
$52.7M Buy
6,910,789
+847,293
+14% +$5.69M 1.92% 15
2018
Q2
$34.7M Sell
6,063,496
-1,302,964
-18% -$7.17M 1.24% 29
2018
Q1
$35.1M Buy
7,366,460
+153,067
+2% +$786K 1.25% 23
2017
Q4
$35.4M Buy
7,213,393
+2,237,942
+45% +$10.8M 1.4% 26
2017
Q3
$26.1M Buy
4,975,451
+1,476,249
+42% +$7.56M 1.18% 31
2017
Q2
$19.5M Buy
3,499,202
+413,966
+13% +$2.52M 1.08% 31
2017
Q1
$25.9M Sell
3,085,236
-152,498
-5% -$1.06M 1.01% 37
2016
Q4
$20.5M Sell
3,237,734
-1,164,112
-26% -$6.06M 0.85% 38
2016
Q3
$19.4M Buy
+4,401,846
New +$17.6M 0.9% 34
2014
Q2
Sell
-907,920
Closed -$9.61M 130
2014
Q1
$9.61M Buy
907,920
+39,350
+5% +$420K 0.44% 64
2013
Q4
$6.6M Sell
868,570
-763,790
-47% -$4.84M 0.37% 68
2013
Q3
$11.9M Buy
+1,632,360
New +$8.28M 0.6% 60

Other funds holding BCRX